PDK4 and familial dilated cardiomyopathy: Such a model would provide a useful platform for more thorough investigations into disease mechanisms of PDK4 deficiency as well as the testing of nutritional supplements, pharmaceuticals, and potentially CRISPR-Cas based genome editing approaches to mitigate the onset and progression of DCM in DPs.